SereNeuro Therapeutics
PrivateLast Round
Grant
May 13, 2025
Total Funding Raised
$5.02M
Momentum Score
25 /100
Company Overview
SereNeuro Therapeutics is a biotechnology company developing non-opioid cell and gene therapies for chronic pain management.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
SereNeuro Therapeutics Comps
Public and private peers based on sector, stage, and business model.
SereNeuro Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 13, 2025 | ||||
| Seed | Feb 28, 2025 | ||||
| Grant | Nov 20, 2023 |
SereNeuro Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Johns Hopkins Technology Ventures | Grant |
| Maryland Stem Cell Research Fund | Grant |
| Ecphora Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 13, 2025
Received funding from the Maryland Stem Cell Research Fund.
- Feb 28, 2025
$5M round led by Ecphora Capital
SereNeuro Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about SereNeuro Therapeutics's valuation, stock price, and market status.
Firmographic Details
HeadquartersBaltimore, Maryland
Employee Range5
Year Founded2023
Last FundingMay 13, 2025
